Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-25

Clinical Trial Update: Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis [Phase 4]

View source ↗

Summary

Phase 4 trial examining whether topical imiquimod influences atrial ectopy in patients with actinic keratosis. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aldara (imiquimod)

Snippet

Sponsor: Medicis Global Service Corporation | Conditions: Actinic Keratosis | Phase 4 | Status: UNKNOWN